to determine the values of imaging and genetic biomarkers for prediction of tumor aggressiveness and prognosis in patient with early stage lung adenocarcinoma to Identify unique copy number alteration in patient with early stage lung adenocarcinoma to evaluate the long-term change of ground-glass nodule combined with lung adenocarcinoma to suggest a guideline for planning an appropriate follow-up examination and management
Study Type
OBSERVATIONAL
Enrollment
200
Duel-energy CT, PET, copy number alteration
Samsung Medical Center
Seoul, South Korea
RECRUITINGPrediction of tumor aggressiveness
Time frame: five years
prognosis of early stage lung adenocarcinoma following operation
Time frame: five years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.